DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pyrrole-2-Carboxylate is an investigational drug.
There have been 5 clinical trials for Pyrrole-2-Carboxylate. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2020.
The most common disease conditions in clinical trials are Pre-Eclampsia, Melanoma, and Venous Thrombosis. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Assiut University, and Second Affiliated Hospital, School of Medicine, Zhejiang University.
There are five hundred and ninety-nine US patents protecting this investigational drug and four international patents.
Recent Clinical Trials for Pyrrole-2-Carboxylate
|Effect of Rosuvastatin on the Clinical Features of Preeclampsia||Assiut University||Phase 2|
|Prophylactic Anticoagulation for Catheter-related Thrombosis||Second Affiliated Hospital, School of Medicine, Zhejiang University||Phase 4|
|Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer||Jiangsu HengRui Medicine Co., Ltd.||Phase 1/Phase 2|
Top disease conditions for Pyrrole-2-Carboxylate
Top clinical trial sponsors for Pyrrole-2-Carboxylate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pyrrole-2-Carboxylate||Start Trial||Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions||Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)||Start Trial|
|Pyrrole-2-Carboxylate||Start Trial||Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions||Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)||Start Trial|
|Pyrrole-2-Carboxylate||Start Trial||1-heterocyclic bicyclo-octanes||The Wellcome Foundation Limited (London, GB2)||Start Trial|
|Pyrrole-2-Carboxylate||Start Trial||Certain phosphonic acids and derivatives useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade||Ciba-Geigy Corporation (Ardsley, NY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pyrrole-2-Carboxylate||European Patent Office||0381142||2009-01-31||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|